Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
112,550
Sort by:
Physician Views: Sanofi's successor to Lantus - are endocrinologists impressed?
US$ 695.00
... hypoglycaemia – currently known as Insulin U300 – is the most important product in Sanofi's late-stage R&D pipeline. With submission to regulators expected next year ... in selected European markets and Japan – there appears to be an opportunity for Sanofi to push home an advantage with U300, particularly by building on the entrenchment ...
November 2013
Healthcare Deal Multiples (Select Transaction) - Part l
US$ 500.00
... of current valuations prevalent in the industry. The report is an extensive analysis of various rounds of funding the companies in Healthcare sector have secured through various Private Equity Transactions. The report projects actual Deal Multiples derived from the statutory filings ...
November 2013
62 pages
Worksite Weight Loss Programs: A Market Analysis
US$ 995.00
... new study by Marketdata examines the $1.2 billion business of worksite-based weight loss programs. This niche segment is one of the few bright spots ... used, findings of various national studies examining employer weight loss programs, worksite competitions, the nature of providers (large commercial and ...
November 2013
147 pages
Production of Niacin in China
US$ 1,192.00
... , which is in great demand in the fast-growing feed industry. The production of niacin in China started in the 1960s with small output. After the 20th ... experienced large capacity expansion, pulling down their prices. Most niacin producers in China adopt 3-picoline, whose capacity has risen from 20,000t ...
November 2013
13 pages
Enanta- It is just the beginning of good news
US$ 90.00
... SVR12 data of SAPPHIRE-I –oral regimen (ENTA’s /ABT-450 boosted Abbvie’s ritonavir, ... data from the first of six Phase III HCV trial of ENTA/AbbVie's using its oral IFN free regimen. ... 1) and regulatory filing in 2nd half of 2014 we expect ENTA shares to appreciate further. We are positive on the PhIII study ...
November 2013
2 pages
Carman's Fine Foods Pty Ltd in Health and Wellness (Australia)
US$ 150.00
Carman’s Fine Foods Pty Ltd continues to seek opportunities to strengthen its position in NH high fibre breakfast cereals and granola/muesli bars by adding new variants to its Carman’s range, while also making more investment to provide marketing support for existing products sold ...
November 2013
2 pages
Dairygold Co-op Society Ltd in Health and Wellness (Ireland)
US$ 150.00
Dairygold Co-op Society Ltd’s presence in health and wellness is thanks to its Be Smoothies brand. Be Smoothies has maintained its value share even in the face of a more general move away from smoothies in the recession thanks to the ‘Love Irish’ marketing tactic, of which Dairygold is perfectly ...
November 2013
2 pages
Green & Blacks Ltd in Health and Wellness (United Kingdom)
US$ 150.00
Having been bought by global brand owner Kraft Foods in 2010, the company is expected to be more focused on becoming a mainstream brand during the forecast period, especially after the move to 100% fair trade. The company will continue to invest in extensive media campaigns as well as increasing its consumer ...
November 2013
2 pages
Hubbards Foods Ltd in Health and Wellness (New Zealand)
US$ 150.00
... company has identified innovation as a key avenue for growth and is expected to provide new and innovative products in regards to the reduced fat, reduced sugar and gluten-free categories of health and wellness breakfast cereals. Hubbards Foods is anticipated to remain as a key player within health ...
November 2013
2 pages
Kerry Group Plc in Health and Wellness (Ireland)
US$ 150.00
Kerry Group will continue to hedge its bets over the forecast period, by expanding its own assortment of health and wellness brands, whilst also manufacturing private label products for leading retailers in Ireland. In terms of its own brands, it will focus on expanding its portfolio to cover ...
November 2013
3 pages
National Foods Pty Ltd in Health and Wellness (Australia)
US$ 150.00
National Foods Pty Ltd was acquired from San Miguel Corp by Kirin Holdings Co Ltd in 2007. Since then, it has remained as a standalone business. However, the 2009 acquisition by Kirin Holdings Co Ltd of Lion Nathan Ltd brought changes as the Japanese brewer sought to consolidate its ...
November 2013
2 pages
Organix Brands Plc in Health and Wellness (United Kingdom)
US$ 150.00
Organix will continue to position itself as a dynamic new company breaking into the organic baby food category, pioneering the healthiest possible options ... and Wellness by Prime Positioning, Health and Wellness by Type. Data coverage: market sizes (historic and forecasts), company shares, brand shares and ...
November 2013
2 pages
Ban Choon Marketing Pte Ltd in Health and Wellness (Singapore)
US$ 150.00
Ban Choon Marketing (Pte) Ltd is expected to extend its product portfolio under organic products further, so it is not limited to food products but also ... reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and ...
November 2013
2 pages
Competitor Analysis: Janus Kinase (JAK) and spleen tyrosine kinase (syk) Inhibitors
US$ 529.00
... developments in the pipeline of inhibitors of the janus-associated kinase (JAK) and of spleen tyrosine kinase provides a competitor evaluation in the field of active ... ) are made up of a family of four cytoplasmic tyrosine kinases—JAK1, JAK2, JAK3, and TYK2—that play pivotal roles in the signaling pathways ...
November 2013
69 pages
India IVF Treatment Market Outlook 2018
US$ 600.00
... IUI, IVF, and ICSI (intra cytoplasmic sperm injection). India has become one of the favored destinations for infertility treatments such as IVF due to several ... health care system. “India IVF Treatment Market Outlook 2018” report by KuicK Research gives comprehensive insight on following aspects related to booming IVF treatment market in India: Market Overview IVF Treatment Market Potential Total Fertility ...
November 2013
54 pages
Global Hearing Aid Market Report: 2013 Edition
US$ 800.00
... , certain people have relative insensitivity to sound. Such situation is termed as hearing impairment. The increase in volume above the usual sound levels ... serious challenges in terms of social stigma and rise in price pressure. The report on global hearing aid market contains a comprehensive analysis of the ...
October 2013
69 pages
Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018)
US$ 800.00
... Scope of the report The report titled “Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018)” provides an in-depth analysis of global rheumatoid arthritis market with special focus on biologics drugs. It also accesses the key opportunities and underlying trends in the market and outlines the ...
October 2013
64 pages
Global Multiple Sclerosis Market: Trends & Opportunities (2013-18)
US$ 700.00
... report titled “Global Multiple Sclerosis Market: Trends & Opportunities (2013-18)“ provide an insight into the market dynamics and various trends and opportunities associated with the global multiple sclerosis market. The report ... contributor to the global multiple sclerosis market has been assessed. The report concludes with a brief discussion of major factors driving the global multiple sclerosis market and profiles major ...
October 2013
54 pages
Global Age-Related Macular Degeneration (AMD) Market: Trends and Opportunities (2013-2018)
US$ 800.00
... Report The report titled “Global Age-Related Macular Degeneration (AMD) Market: Trends & Opportunities (2013-2018)” provides an in-depth analysis of the global age-related macular degeneration market with detailed analysis of various ... Age-related macular degeneration (AMD) is a condition affecting older people, and involves the loss of the person's central field of vision. Several forms of AMD exist such as early AMD ...
October 2013
70 pages
2013 Healthcare Benchmarks: Dual Eligibles Care Coordination
US$ 107.00
... adherence, patient satisfaction, pharma costs, and other key metrics; ROI from duals care management; Greatest care coordination successes achieved; and much more. 2013 Healthcare Benchmarks: Dual Eligibles Care Coordination also delivers advice from Dr. Timothy Schwab, the ...
October 2013
40 pages
2013 Healthcare Benchmarks: Accountable Care Organizations
US$ 127.00
... a greater number of ACOs in the wings than one year ago. 2013 Healthcare Benchmarks: Accountable Care Organizations documents the numerous ways in which ... ACOs — in the respondents' own words. Impact of ACO model on population health, healthcare spend and other indicators; Early successes from ACOs; and The ...
October 2013
65 pages
Sports Medicine Market Report: 2013 Edition
US$ 800.00
... sports medicine market, the report also analyzes the global orthopedics market and global arthroscopic market. The report elicits the intricacies of market size, factors influencing market ... expense. The report also provides company profiles of the key players in the global sports medicine market along with a ...
October 2013
48 pages
Coronary Stents Market in India 2013
US$ 950.00
... after order is placed. Netscribes’ latest market research report titled Coronary stents Market in India 2013 states that manufacturers of coronary stents are experiencing high demand for their ... form of a much needed regulatory mechanism and will benefit the coronary stents market as well.
October 2013
134 pages
Cooperativa Agrícola y Lechera de la Union Ltda in Health and Wellness (Chile)
US$ 150.00
Cooperativa Agrícola y Lechera de La Unión Ltda (Colun) continues to innovate with the goal of gaining value share within health and wellness. In 2012, the company launched its digestive yoghurt called Vilib Digestion to compete directly with Activia from Soprole and Danone’s Activia. The ...
October 2013
2 pages
Barilla Alimentare SpA in Health and Wellness (Italy)
US$ 150.00
... well. Expanding its better for you portfolio is a key strategy at Barilla, especially as the link between health and... Euromonitor International Local Company Profiles are ... data. Why buy this report? Get a detailed picture of the Health and Wellness market; Pinpoint growth sectors and identify factors ...
October 2013
2 pages
China Medical Materials & Supplies Market Report
US$ 680.00
... … This report covers following sections. Market Size Based on Zeefer's China Market Size Formula, by the analysis on market size, industry sales ... the structure and concentration ratio of the current medical materials & supplies market in China by means of Bain's Market Structure Classification and Index ...
October 2013
51 pages
Market Access Collection
US$ 4,095.00
The collection includes the following reports: Market Access Canada Market Access in the EU5 – a comparative overview Value-based Key Account Management and the NHS – ensuring optimal performance under new rules Biosimilars in Emerging Markets
October 2013
Marketing Collection
US$ 6,495.00
The collection includes the following reports: Pharma and Gamification: motivating positive outcomes – a primer The Impact of Mobile Health on Patient-Centric ... real-world commercial benefit from closed-loop marketing Driving Brand Value in Emerging Markets - winning strategies and tactics Big Data ...
October 2013
Medical Affairs Collection
US$ 2,295.00
The collection includes the following reports: MSL-KOL Engagement: delivering value under new rules Ensuring Optimal Medical Affairs Performance: Delivering Measurable Value The Path to Product Inclusion in Clinical Guidelines: Strategies for Success ...
October 2013
Emerging Markets Collection
US$ 3,295.00
The collection includes the following reports: Inside China’s Pharma Sales Force – insights from the frontline Branded Generics: Strategies and Tactics for Winning in Latin America Biosimilars in Emerging Markets Driving Brand Value in Emerging Markets - winning strategies and tactics
October 2013
Salim Ivomas Pratama Tbk PT in Health and Wellness (Indonesia)
US$ 150.00
The company is expected to continue expanding its palm oil plantations, palm mills and invest in improving yields from its plantations. The company is also expected to expand its sugar cane plantation and sugar manufacturing facilities in line with its parent company’s bid to become, according to Kompas ...
October 2013
3 pages
Tangmas PT in Health and Wellness (Indonesia)
US$ 150.00
... Frutang Bulir (Frutang FF fruit-flavoured drinks with orange pulp) in 2011, Tangmas is expected to come up with more innovative HW beverages in the forecast period. ... data. Why buy this report? Get a detailed picture of the Health and Wellness market; Pinpoint growth sectors and identify factors driving ...
October 2013
3 pages
Regeneron - Eylea’s Growth Potential and Pipeline is Lucrative Enough!
US$ 140.00
... of Eylea (aflibercept, VEGF-Trap Eye, L, wet-AMD, Central Retinal Vein Occlusion – CRVO, partnered with Bayer for ex-US) in Diabetic Macular Edema (DME) and myopic choroidal neovascularization (mCNV) and promise of the late-stage pipeline esp. anti-PCSK9 mAb, Alirocumab (REGN727, PhIII, Hypercholesterolemia ...
October 2013
7 pages
Les Huileries de Oued Souss in Health and Wellness (Morocco)
US$ 150.00
... its product portfolio will continue to be the main strategic plan for Les Huileries de Oued Souss. As the company operates mainly in the slow-growing mature category of NH olive oil, Les Huileries de Oued Souss will seek to invest in other HW food categories and this move to healthier products was ...
October 2013
2 pages
Ruohonjuuri Oy in Health and Wellness (Finland)
US$ 150.00
Ruohonjuuri Oy expanded from a single outlet marginal retailer to a health and wellness grocery supermarket chain with four outlets. The chain aims to ... and distribution data. Why buy this report? Get a detailed picture of the Health and Wellness market; Pinpoint growth sectors and identify factors driving ...
October 2013
2 pages
Uni-President Enterprises Corp in Health and Wellness (Taiwan)
US$ 150.00
Uni-President Enterprises Corp will continue to employ its extensive expertise in food and retail to remain a key player in health and wellness. As the owner of some of Taiwan’s leading distribution channels, the company is likely to be one of the first to ...
October 2013
2 pages
Thailand Medical Tourism Market (Spending) Analysis & Forecast
US$ 1,290.00
... report titled 'Thailand Medical Tourism Market (Spending) Analysis & Forecast' provides a comprehensive analysis of the Thailand medical tourism market covering in detail ... . All the 15 countries in the report have been studied from 2 viewpoints. Medical Tourists Visits in Thailand from the year 2001-2018 ...
October 2013
112 pages
Smoking Cessation - Data, Analysis & Forecasts to 2023
US$ 3,000.00
GMR Data’s new pharmaceutical report outlines the factors affecting the global smoking cessation market across the forecast period 2013- ... this crucial information this report offers analysis and opinion on current R&D in the smoking cessation sector alongside in depth analysis of the emerging, global e- ...
October 2013
101 pages
ABLYNX - Nanobodies - Turnarond on the Horizon!
US$ 140.00
... of ALX-0061 (PhI/II, Anti-IL6R, RA) with AbbVie under attractive terms (deal value of $840m/~€630m) and news flow in last one year brought back Ablynx (ABLX ... ) and its nanobody platform’s’ potential in the limelight! Though ABLX suffered from several setbacks in 2011, ...
October 2013
7 pages
Japanese Market for Wound and Tissue Management
US$ 6,995.00
... 2012, the Japanese market for wound and tissue management was valued at over $1.5 billion, a 1.6% increase over 2011. The wound and ... period of 10 years (2009 – 2019) for Japan. Report Contents: Competitor Analysis Identified Strategic Opportunities Market Overview by Segment Trend Analysis by Segment ...
October 2013
164 pages
Merck Update: HCV combo, Lambrolizumab and Corporate Restructuring Program
US$ 90.00
Merck announced restructuring (cost efficiency) program which is likely to ... by 2015) announced by the Company through workforce reduction across all functional divisions, head quarter relocation, out ... . More focused attention on therapy areas where Merck has proven its abilities irrespective of unmet need ...
October 2013
3 pages
Global Oncolytic Virus Therapy Pipeline Analysis
US$ 1,500.00
... survival solutions with significant importance. Also, the side effects of this therapy would be tolerable by the patients, which could thus become the ... selective without the need for any genetic manipulation. “Global Oncolytic Virus Therapy Pipeline Analysis” by PNS Pharma gives comprehensive insight on the ...
October 2013
105 pages
Chronic Obstructive Pulmonary Disorder (COPD) - KOL Insight and Consensus Outlook
US$ 7,495.00
The prevalence of Chronic Obstructive Pulmonary Disorder (COPD) is increasing globally, its impact on the wider health economy is significant and there remains ... , products, late-stage pipeline drugs, product positioning, in the context of COPD market trends. Event Bulletins Benefit from the latest KOL ...
September 2013
157 pages
